# Resveratrol supplementation improves uterine immune resolution in mares susceptible to persistent breeding-induced endometritis

**Authors:** Genevieve Denison, Javier Funes, Patricio Razquin, Jocelyn Howard, Isabela Hamner, Lyta Foulk, Chelsie Burden, Jenn N. Hatzel, Jenny L. Sones, Pat M. McCue, Carleigh E. Fedorka

PMC · DOI: 10.3389/fvets.2026.1760273 · Frontiers in Veterinary Science · 2026-02-16

## TL;DR

Resveratrol may help reduce inflammation in mares prone to persistent breeding-induced endometritis, potentially improving their reproductive outcomes.

## Contribution

This study is the first to investigate resveratrol's effect on uterine inflammation in PBIE-susceptible mares.

## Key findings

- Resveratrol reduced neutrophil counts in uterine fluid samples at 6 and 24 hours post-breeding.
- Cytokine profiling showed trends toward decreased IL-1β and IL-8, and increased IL-6 after resveratrol treatment.
- The results suggest resveratrol modulates the uterine inflammatory response in PBIE-susceptible mares.

## Abstract

Persistent breeding-induced endometritis (PBIE) remains a major problem in equine reproduction. This disorder is characterized by prolonged post-breeding inflammation and is associated with advanced age, reduced endometrial quality, and impaired uterine immune function. Resveratrol, a polyphenolic compound with documented anti-inflammatory activity in humans, has not been investigated for its ability to modulate uterine inflammation in mares. We hypothesized that resveratrol supplementation would attenuate the exaggerated inflammatory response characteristic of PBIE-susceptible mares.

Six susceptible mares completed a control cycle followed by 21.8 ± 0.8 days of oral resveratrol treatment (2,800 g SID). During both cycles, mares were inseminated with 500 × 106 freezekilled spermatozoa and evaluated at 6 and 24 h post-breeding. Uterine fluid was quantified via transrectal ultrasonography, and neutrophil counts were assessed using cytobrush and low-volume lavage (LVL). Luminal cytokines were measured with an equine multiplex immunoassay. Data were analyzed using a general linear model in SAS 9.4® (p ≤ 0.05).

Resveratrol supplementation did not alter uterine fluid accumulation (p = 0.35) but reduced neutrophilia in LVL samples at 6 h (p = 0.09) and 24 h (p = 0.03), as well as in cytobrush samples at 24 h (p = 0.04). Cytokine profiling revealed a trend toward decreased IL-1β at 6 h (p = 0.06) with a concurrent increase in IL-6 (p = 0.04) and a trend toward reduced IL-8 at 24 h (p = 0.09).

These findings demonstrate that resveratrol modulates specific components of the uterine inflammatory response in PBIE-susceptible mares. Such immunomodulatory effects may have relevance for improving reproductive efficiency, warranting further mechanistic and clinical investigation.

Infographic illustrating a study on six mares susceptible to persistent breeding-induced inflammation, receiving twenty-one days of oral resveratrol. Key findings include reduced uterine neutrophils, decreased IL-8 and IL-1β, and increased IL-6, suggesting resveratrol may improve reproductive efficiency by reducing inflammation.

## Linked entities

- **Chemicals:** resveratrol (PubChem CID 5056), IL-6 (PubChem CID 165368475), IL-8 (PubChem CID 169410440)
- **Species:** Equus caballus (taxon 9796)

## Full-text entities

- **Genes:** insulin [NCBI Gene 100060077], IL-6 [NCBI Gene 100034196], TNF [NCBI Gene 100033834], IL-8 [NCBI Gene 100037400], leptin [NCBI Gene 100034042], myeloperoxidase [NCBI Gene 100070920], IL-1RN [NCBI Gene 100034236], IL-1beta [NCBI Gene 100034237], IL-10 [NCBI Gene 100034187]
- **Diseases:** embryonic loss (MESH:D020964), rheumatoid arthritis (MESH:D001172), beta-streptococcus infection (MESH:D011008), PCOS (MESH:D011085), carcinogenic (MESH:D011230), Neutrophilia (MESH:C563010), infection (MESH:D007239), immune deficits (MESH:D007154), infertility (MESH:D007246), lethargy (MESH:D053609), abdominal discomfort (MESH:D000007), LVL (MESH:D009800), airway inflammation (MESH:D007249), fibrosis (MESH:D005355), Fluid (MESH:D002559), endometriosis (MESH:D004715), preeclampsia (MESH:D011225), CF (MESH:D003550), edema (MESH:D004487), anorexia (MESH:D000855), diarrhea (MESH:D003967), PBIE (MESH:D004716), lupus (MESH:D008180), anaphylaxis (MESH:D000707)
- **Chemicals:** LVL (-), amikacin (MESH:D000583), malondialdehyde (MESH:D008315), polyphenol (MESH:D059808), ROS (MESH:D017382), nitrogen (MESH:D009584), agar (MESH:D000362), water (MESH:D014867), luminal (MESH:D010634), Resveratrol (MESH:D000077185)
- **Species:** Homo sapiens (human, species) [taxon 9606], Equus caballus (domestic horse, species) [taxon 9796], Crohivirus B (no rank) [taxon 2169854], Arachis hypogaea (goober, species) [taxon 3818]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951475/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951475/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951475/full.md

---
Source: https://tomesphere.com/paper/PMC12951475